N-(1-benzylpiperidin-4-yl)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-amine | 1456859-25-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: N-(1-benzylpiperidin-4-yl)-6-bromo-2,3,4,9-tetrahydro-1H-carbazol-1-amine
• CAS: 1456859-25-8
• 化学式: C₂₄H₂₈BrN₃
• 分子量: 438.41
• InChiKey: MUOBMXMDJBVYFV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  28
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  31.1
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• [EN] NOVEL MEANS AND METHODS FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM, METABOLIC AND CARDIAC DISEASES AND AGING<br/>[FR] NOUVEAUX MOYENS ET MÉTHODES POUR LE TRAITEMENT DE MALADIES DU SYSTÈME NERVEUX CENTRAL, DE MALADIES CARDIAQUES ET MÉTABOLIQUES ET DU VIEILLISSEMENT
  申请人：UNIV MUENCHEN L MAXIMILIANS

  公开号：WO2013139929A1

  公开（公告）日：2013-09-26

  This invention relates to a compound of formula (la) or (Ila) wherein either (A) R1 is I and R2 is selected from substituted or unsubstituted piperidinyl, preferably N-substituted or unsubstituted piperidin-4-yl; substituted or unsubstituted cyclohexyl, cyclopentyl, or cyclohexyl alkyl; substituted or unsubstituted aryl-alkyl; alkyl; aryl; - CHO; and hydrogen; or (B) R1 is selected from halogen; substituted or unsubstituted alkoxy; substituted or unsubstituted alkyl; cyano; and hydrogen; and R2 is substituted or unsubstituted piperidinyl, preferably N-substituted or unsubstituted piperidin-4-yl; and R3, R4 and R5 independently are either H or defined as R1; R6 is H; alkyl or aryl-alkyl, or R2 and R6 together with the N attached thereto form a 5- or 6-membered ring, preferably pyrrol; each of the m occurrences of R7 is independently selected from C1 to C4 alkyl, C1 to C4 alkoxy and halogen, preferably F; and m being 0, 1, 2, 3 or 4; X is selected from NH; N-alkyl, preferably NCH3; N- aryl-alkyl; S; and O; wherein in formula (la) R2 and X together may alternatively form or comprise a 6-membered ring, said 6-membered ring preferably being piperazine; n is 0, 1 or 2; the substituents being independently selected from alkyl, aryl-alkyl; alkoxy, aryl, hydroxy; halogen; oxo; and thio; alkyl being branched, unbranched and/or cyclic C1 to C10 alkyl, preferably branched or unbranched C1 to C4 alkyl, more preferably methyl, ethyl, n-propyl, i- propyl, i-butyl or t-butyl; alkoxy being C1 to C4 alkoxy, preferably methoxy; aryl being phenyl, naphthyl or tetrahydronaphthyl, preferably phenyl; or a compound of any one of Tables 3 to 46; or a salt or hydrate thereof.

  本发明涉及一种化合物，其化学式为（Ia）或（IIa），其中（A）R1为I，R2选自取代或未取代的哌啶基，优选N-取代或未取代的哌啶-4-基；取代或未取代的环己基、环戊基或环己基烷基；取代或未取代的芳基-烷基；烷基；芳基；-CHO；和氢；或者（B）R1选自卤素；取代或未取代的烷氧基；取代或未取代的烷基；氰基；和氢；R2为取代或未取代的哌啶基，优选N-取代或未取代的哌啶-4-基；R3、R4和R5独立地为H或被定义为R1；R6为H；烷基或芳基-烷基，或者R2和R6与其连接的N共同形成5-或6-成员环，优选吡咯；每个R7的m次出现独立地选自C1到C4烷基、C1到C4烷氧基和卤素，优选F；m为0、1、2、3或4；X选自NH；N-烷基，优选NCH3；N-芳基-烷基；S；和O；其中在化学式（Ia）中，R2和X共同可以形成或包含一个6-成员环，该6-成员环优选为哌嗪；n为0、1或2；取代基独立地选自烷基、芳基-烷基；烷氧基、芳基、羟基；卤素；氧化物；和硫代基；烷基为支链、直链和/或环状C1到C10烷基，优选支链或直链C1到C4烷基，更优选甲基、乙基、正丙基、异丙基、异丁基或叔丁基；烷氧基为C1到C4烷氧基，优选甲氧基；芳基为苯基、萘基或四氢萘基，优选苯基；或者为表3至表46中的任一化合物；或其盐或水合物。